Cat.#: ACPP-1091
| Despition | BMP11 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1218 | Dopamine D2 Receptor Blocking Peptide (AC1218) | 250 µg | inquiry |
| ACPP-1621 | Human LZIC Protein (AC1621) | 5 µg | inquiry |
| ACPP-1276 | MAP3K4 Blocking Peptide (AC1276) | 250 µg | inquiry |
| ACPP-1477 | Mouse I TAC Protein (AC1477) | 5 µg | inquiry |
| ACPP-1036 | Recombinant Human ANGPTL7 Protein (6×His Tag) (AC1036) | 50 µg | inquiry |
| ACPP-1369 | Parkin Blocking Peptide (AC1369) | 250 µg | inquiry |
| ACPP-1216 | PARD3 Blocking Peptide (AC1216) | 250 µg | inquiry |
| ACPP-1155 | Recombinant Human PCDH18 Protein (6×His Tag) (AC1155) | 50 µg | inquiry |
| ACPP-1679 | Human SYT4 Protein (AC1679) | 2 µg | inquiry |
| ACPP-1426 | Human ENO2 Protein (AC1426) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.